InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton’s tyrosine kinase) ...
Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results